Recombinant Saccharomyces cerevisiae Stationary phase-expressed protein 1 (SPG1)

Shipped with Ice Packs
In Stock

Description

Key Properties

PropertyDetailsSource
Gene IDEntrez Gene ID: 853151 (S288C strain)
Protein Length95 amino acids
TagsN-terminal 10xHis-tag (recombinant forms)
Purity≥85% (SDS-PAGE validated)
LocalizationMitochondria (detected in high-throughput studies)

Functional Roles and Biological Significance

SPG1 is essential for survival during stationary phase under stress conditions, such as elevated temperatures. It interacts with multiple cellular components to regulate stress adaptation:

Predicted Functional Partners

Partner GeneProtein NameRole in Stress ResponseInteraction Score
SPG4Stationary phase protein 4High-temperature survival0.634
TEM1GTP-binding protein TEM1Septin dynamics and cytokinesis0.597
SIP18Phospholipid-binding hydrophilinOsmotic stress resistance0.569
CDC7DDK kinase subunitDNA replication and repair0.550
CDC14Tyrosine-protein phosphataseMitotic exit and stress response0.482

Data derived from STRING interaction network analysis .

SPG1’s role in mitochondrial function and stress adaptation is further supported by its detection in highly purified mitochondrial fractions . Experimental studies using SILAC (Stable Isotope Labeling by Amino acids in Cell culture) and mass spectrometry have validated its half-life and abundance under varying conditions .

Recombinant Production and Applications

SPG1 is commercially produced via recombinant expression systems, primarily in E. coli or yeast, with applications in research and biotechnological studies.

Production and Supplier Information

SupplierHost SystemPurityAvailability
CUSABIO TECHNOLOGY LLCE. coli≥85% (SDS-PAGE)China
MyBioSourceCell-free systems≥85% (SDS-PAGE)Global
GenScriptE. coliCustom cloningUSA

Sources: .

Recombinant SPG1 is used to study:

  • Stress adaptation mechanisms: High-temperature survival pathways.

  • Mitochondrial dynamics: Protein localization and interactions.

  • Industrial applications: Enhancing yeast resilience in fermentation processes under adverse conditions .

Stress Response and Survival

SPG1 is indispensable for survival during stationary phase, particularly at elevated temperatures. Knockout studies reveal impaired septum formation and elongated, multinucleate cells under stress , though this finding pertains to Schizosaccharomyces pombe (fission yeast). In S. cerevisiae, SPG1’s mitochondrial localization suggests a role in maintaining organelle integrity during stress .

Post-Translational Modifications

Experimental evidence highlights potential modification sites (e.g., phosphorylation, ubiquitination) critical for its function. These modifications influence protein stability and interaction networks .

Product Specs

Form
Lyophilized powder
Note: While we will prioritize shipping the format currently in stock, we understand that you may have specific requirements. Please include any format preferences in your order notes, and we will do our best to accommodate your needs.
Lead Time
Delivery timelines may vary depending on the purchase method and location. Please consult your local distributors for specific delivery estimates.
Note: All of our proteins are standardly shipped with blue ice packs. If dry ice shipping is required, please contact us in advance, as additional fees may apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly prior to opening to ensure the contents settle at the bottom. Please reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%. Customers may use this as a reference.
Shelf Life
Shelf life is influenced by several factors, including storage conditions, buffer ingredients, storage temperature, and the inherent stability of the protein itself.
Generally, liquid formulations have a shelf life of 6 months at -20°C/-80°C. Lyophilized formulations have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you have a specific tag type requirement, please inform us, and we will prioritize development of the specified tag.
Synonyms
SPG1; SCRG_00788; Stationary phase-expressed protein 1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-95
Protein Length
full length protein
Species
Saccharomyces cerevisiae (strain RM11-1a) (Baker's yeast)
Target Names
SPG1
Target Protein Sequence
MKLDSGIYSEAQRVVRTPKFRYIMLGLVGAAVVPTAYMRRGYTVPAHSLDNINGVDTTKA SVMGTEQRAAMTKGKSLQEMMDDDEVTYLMFSSIM
Uniprot No.

Target Background

Subcellular Location
Mitochondrion membrane; Single-pass membrane protein.

Q&A

What is Saccharomyces cerevisiae Stationary Phase-Expressed Protein 1 (SPG1)?

SPG1 (Stationary Phase Gene 1) is a protein-coding gene found in Saccharomyces cerevisiae S288C, commonly known as baker's yeast. The protein is specifically expressed during the stationary phase of yeast growth, suggesting its involvement in stress response or adaptation to nutrient limitation. SPG1 has been identified through genomic sequencing efforts, including the comprehensive Saccharomyces cerevisiae genome project that identified approximately 6000 genes . The full-length protein consists of 95 amino acids and is categorized as a stationary phase-expressed protein, indicating its functional relevance during non-proliferative cellular states .

What is the genomic organization and expression pattern of the SPG1 gene?

The SPG1 gene is located on chromosome VII of Saccharomyces cerevisiae, as identified through the nucleotide sequencing project described by Tettelin et al. . Its Entrez Gene ID is 853151, and the gene encodes a relatively small protein (95 amino acids) . The expression pattern of SPG1 is characterized by its upregulation during the transition from exponential growth to stationary phase, when nutrients become limiting and yeast cells undergo significant metabolic and physiological changes. The gene's expression is typically low during active growth phases and increases as cells enter stationary phase, making it a valuable marker for studying this transition.

FeatureInformationSource
Gene SymbolSPG1
Entrez Gene ID853151
Full NameStationary Phase Gene 1 Protein (Spg1p)
Gene TypeProtein-coding
OrganismSaccharomyces cerevisiae S288C
Protein LengthFull Length (1-95 amino acids)
Reference mRNANM_001181365.3
Reference ProteinNP_011752.4

How should I design initial experiments to characterize SPG1 expression?

When designing experiments to characterize SPG1 expression, it is crucial to follow established principles of experimental design to ensure reliable and reproducible results3 . Begin with a clear hypothesis about SPG1 expression patterns during different growth phases. Designate SPG1 expression level as your dependent variable and growth phase or environmental condition as your independent variable3. For accurate quantification, real-time PCR or Western blotting with specific antibodies can be employed to monitor expression levels.

A well-designed experiment should include:

  • Time-course sampling during yeast growth from early exponential to late stationary phase

  • Appropriate controls, including housekeeping genes with constant expression

  • Technical and biological replicates to ensure statistical robustness

  • Validation using multiple measurement techniques

Statistical analysis should include ANOVA for comparing expression levels across multiple time points, followed by appropriate post-hoc tests to identify significant differences between specific phases . Power analysis should be conducted prior to experimentation to determine the necessary sample size for detecting biologically meaningful differences in expression .

How can I optimize the production of recombinant SPG1 protein for structural studies?

Optimizing recombinant SPG1 production requires systematic evaluation of expression systems and conditions. Based on available data, recombinant SPG1 has been successfully expressed in E. coli using His-tag purification strategies . For structural studies, consider the following optimization approaches:

  • Expression vector selection: Compare expression levels in multiple vectors with different promoters and fusion tags

  • Host strain optimization: Test multiple E. coli strains specialized for recombinant protein expression

  • Induction conditions: Systematically vary IPTG concentration, temperature, and induction duration

  • Protein solubility enhancement: Test co-expression with chaperones or modified culture conditions

When designing these experiments, implement factorial experimental designs to efficiently identify optimal conditions and potential interaction effects between variables . Document all expression and purification yields quantitatively to enable statistical comparison between conditions. Pure recombinant protein should be verified by SDS-PAGE, Western blotting, and mass spectrometry to confirm identity and integrity.

What analytical approaches should I use to investigate SPG1 protein-protein interactions?

Investigating SPG1 protein-protein interactions requires multiple complementary approaches to establish confidence in identified interaction partners. Begin with computational prediction tools to generate hypotheses about potential interaction partners based on sequence homology and co-expression patterns. Then proceed with experimental validation using the following techniques:

  • Yeast two-hybrid screening to identify binary interactions in vivo

  • Co-immunoprecipitation with tagged SPG1 followed by mass spectrometry

  • Proximity labeling approaches (BioID or APEX) to capture transient interactions

  • In vitro pull-down assays using purified recombinant SPG1

For each approach, proper experimental controls are essential to distinguish true interactions from background3. Negative controls should include non-specific proteins of similar size and properties. For quantitative analysis of interaction strength, techniques such as microscale thermophoresis or surface plasmon resonance can provide binding affinity measurements. Data analysis should account for potential false positives through statistical filtering and require detection by multiple independent methods for high-confidence interactions.

How does SPG1 expression respond to various stress conditions beyond nutrient limitation?

To comprehensively characterize SPG1 expression under diverse stress conditions, design experiments that systematically expose yeast cultures to various stressors while monitoring SPG1 expression. The independent variable in these experiments would be the stress condition, while the dependent variable would be SPG1 expression level3.

Design a factorial experiment that tests the following stress conditions:

  • Oxidative stress (hydrogen peroxide, menadione)

  • Heat shock (elevated temperatures)

  • Osmotic stress (high salt concentration)

  • pH stress (acidic and alkaline conditions)

  • DNA damage agents (UV radiation, MMS)

For each condition, collect samples at multiple time points to capture both immediate and adaptive responses. Implement appropriate statistical methods to analyze the resulting data, including two-way ANOVA to assess the effects of both stress type and duration . This approach allows for the identification of specific stress conditions that significantly impact SPG1 expression and possible interactions between different stressors.

What controls are essential when designing knockout or overexpression studies for SPG1?

  • Wild-type parental strain as the primary control

  • Complementation control (re-introducing SPG1 to the knockout strain)

  • Knockout of an unrelated gene with similar expression pattern

  • Empty vector control for the knockout construct

For overexpression studies, essential controls include:

  • Empty vector control under identical promoter

  • Overexpression of an unrelated protein of similar size

  • Expression level validation using qPCR and Western blotting

  • Growth rate monitoring to detect potential toxicity effects

Power analysis should determine appropriate sample sizes to detect expected effect sizes . Design the experiment to include biological replicates (multiple independent transformants) and technical replicates to account for variability. Statistical analysis should compare phenotypes using appropriate tests based on data distribution, with correction for multiple comparisons when assessing multiple phenotypes.

How should I approach statistical analysis of complex SPG1 expression data?

Analyzing complex SPG1 expression data requires robust statistical approaches appropriate to experimental design . Begin with exploratory data analysis, including normality testing and variance homogeneity assessment, to determine appropriate statistical methods. For time-course experiments with multiple conditions, consider:

  • Linear mixed-effects models to account for repeated measurements

  • Two-way ANOVA for analyzing effects of multiple factors and their interactions

  • Post-hoc tests with appropriate multiple testing correction (e.g., Tukey, Bonferroni, or FDR)

  • Principal component analysis for identifying patterns in high-dimensional data

Model selection techniques should be applied to identify the most parsimonious statistical model that explains the data . Document and report all statistical assumptions, transformations, and parameters used in the analysis to ensure reproducibility. When possible, validate findings with an independent dataset or experimental approach.

What purification strategies yield the highest activity for recombinant SPG1?

Purifying recombinant SPG1 while maintaining its native activity requires careful optimization of isolation conditions. Based on available recombinant protein information, SPG1 has been successfully expressed with His-tags in E. coli systems . A systematic purification strategy should include:

Purification StepMethod OptionsOptimization Parameters
Initial CaptureIMAC (Ni-NTA for His-tagged SPG1)Imidazole concentration, pH, flow rate
Secondary PurificationSize exclusion chromatographyBuffer composition, salt concentration
Tertiary Purification (if needed)Ion exchange chromatographypH, ionic strength gradient
Activity PreservationBuffer optimizationStabilizing additives (glycerol, reducing agents)
Quality ControlSDS-PAGE, Western blot, mass spectrometryPurity assessment, integrity verification

When designing the purification protocol, implement a fractional factorial design to efficiently identify optimal conditions with minimal experiments . Each fraction should be assessed for both protein yield and activity using appropriate biochemical assays. Document protein stability under various storage conditions to establish optimal preservation methods for maintaining long-term activity.

How can I develop reliable assays to measure SPG1 activity in vitro and in vivo?

Developing reliable assays for SPG1 activity requires understanding its biochemical function and creating appropriate measurement systems. While specific activity assays for SPG1 are not detailed in the search results, a systematic approach to assay development should include:

  • In vitro biochemical assays:

    • Substrate binding assays if targets are known

    • Enzymatic activity measurements if SPG1 has catalytic functions

    • Structural stability assays (thermal shift, circular dichroism)

    • Interaction assays with known binding partners

  • In vivo functional assays:

    • Complementation assays in SPG1 knockout strains

    • Reporter gene constructs fused to SPG1-dependent promoters

    • Growth assays under stationary phase conditions

    • Stress resistance phenotypes in SPG1 mutants

For each assay, establish standard curves, detection limits, and reproducibility metrics3. Validate assays by confirming that they can detect known alterations in SPG1 function, such as differences between wild-type and mutant variants. Use appropriate statistical methods to determine assay precision, accuracy, and dynamic range .

What approaches should I use to study the evolutionary conservation of SPG1 across yeast species?

Studying evolutionary conservation of SPG1 requires comprehensive comparative genomics and functional analysis across multiple yeast species. Begin with bioinformatic approaches to identify potential SPG1 homologs:

  • BLAST searches against genomic databases of diverse yeast species

  • Phylogenetic analysis to establish evolutionary relationships

  • Protein domain conservation analysis

  • Synteny mapping to identify conserved genomic contexts

Follow bioinformatic analysis with experimental validation:

  • Expression profiling of homologs during stationary phase in different species

  • Cross-species complementation studies (can homologs rescue SPG1 knockout phenotypes?)

  • Comparative biochemical characterization of recombinant homologs

  • Analysis of selection pressure (dN/dS ratios) across coding sequences

Design experiments that assess both sequence and functional conservation3. Statistical analysis should incorporate phylogenetic correction methods when comparing traits across species . Document conservation patterns across key functional domains and regulatory regions to gain insights into the evolutionary importance of different protein features.

What are the key considerations for designing a comprehensive SPG1 research program?

Designing a comprehensive research program for SPG1 requires integration of multiple experimental approaches and careful consideration of experimental design principles. Begin by formulating clear research questions that address gaps in current knowledge about SPG1 function and regulation3 . Develop a strategic plan that progresses from basic characterization to more complex functional studies.

Key considerations include:

  • Systematic experimental design with appropriate controls and statistical power

  • Multi-omics integration (genomics, transcriptomics, proteomics, metabolomics)

  • Genetic manipulation strategies (CRISPR-Cas9, classical genetics)

  • Collaborative approaches to access specialized techniques and equipment

  • Replication and validation across multiple experimental systems

Implement rigorous statistical approaches throughout the research program, including power analysis for sample size determination and appropriate statistical tests for data analysis . Incorporate pilot studies to refine methods before full-scale implementation. Regular reassessment of research directions based on emerging data will ensure the program remains focused on the most promising aspects of SPG1 biology.

How can I integrate SPG1 research findings into broader understanding of stationary phase biology?

Integrating SPG1 research findings into the broader context of stationary phase biology requires systematic approaches to data synthesis and interpretation. As you accumulate experimental data on SPG1, consider:

  • Network analysis to position SPG1 within known stationary phase response pathways

  • Comparative analysis with other stationary phase-expressed genes

  • Systems biology modeling to predict emergent properties

  • Meta-analysis incorporating published datasets related to stationary phase

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.